3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasm Metastasis
1
Breast Neoplasms
1
Interventions
pembrolizumab
29
Carboplatin
15
Nivolumab
13
Cisplatin
12
atezolizumab
11
venetoclax
10
Paclitaxel
10
Pemetrexed
9
Ipilimumab
9
Docetaxel
9
Radiotherapy
8
Bevacizumab
8
fludarabine
7
durvalumab
7
Specimen Handling
7
Gemcitabine
7
Cyclophosphamide
7
Cetuximab
7
fludarabine phosphate
6
Practice Guidelines as Topic
6
Biopsy
6
tislelizumab
5
enzalutamide
5
Trastuzumab
5
Standard of Care
5
Radiosurgery
5
Radiation
5
Oxaliplatin
5
Magnetic Resonance Spectroscopy
5
Injections
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Association
×
90 days
×
Clear all
NCT01613482
2026-03-16
TSARINE
Centre Oscar Lambret
Phase 3
Terminated
13 enrolled